Bank of Montreal’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-153
| Closed | -$11K | – | 4636 |
|
2021
Q1 | $11K | Sell |
153
-555
| -78% | -$39.9K | ﹤0.01% | 3948 |
|
2020
Q4 | $85K | Buy |
708
+515
| +267% | +$61.8K | ﹤0.01% | 3221 |
|
2020
Q3 | $17K | Sell |
193
-140
| -42% | -$12.3K | ﹤0.01% | 3501 |
|
2020
Q2 | $40K | Buy |
+333
| New | +$40K | ﹤0.01% | 3170 |
|
2020
Q1 | – | Sell |
-440
| Closed | -$30K | – | 4212 |
|
2019
Q4 | $30K | Buy |
440
+136
| +45% | +$9.27K | ﹤0.01% | 3560 |
|
2019
Q3 | $32K | Buy |
304
+7
| +2% | +$737 | ﹤0.01% | 3346 |
|
2019
Q2 | $27K | Buy |
297
+294
| +9,800% | +$26.7K | ﹤0.01% | 3552 |
|
2019
Q1 | $0 | Sell |
3
-34
| -92% | – | ﹤0.01% | 4260 |
|
2018
Q4 | $2K | Buy |
37
+19
| +106% | +$1.03K | ﹤0.01% | 4065 |
|
2018
Q3 | $2K | Buy |
18
+1
| +6% | +$111 | ﹤0.01% | 4082 |
|
2018
Q2 | $2K | Buy |
+17
| New | +$2K | ﹤0.01% | 4079 |
|